Antiproliferative activity of the bioactive compound from Silybum marianum in a human melanoma cell line with BRAF mutation: potential for therapeutic repurposing. (2025). Revista Fitos, 19, e1812. https://doi.org/10.32712/2446-4775.2025.1812